#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
David Brown Email
Director Chemistry . Seal Rock Therapeutics
Seattle, WA
LocationPrimary Email
How to contact David Brown
Join and see David's contact info for free!Current Roles
Employees:
9Revenue:
$1.4MAbout
Seal Rock Therapeutics, Inc. is discovering and developing small molecule inhibitors of ASK1 (apoptosis signal-regulating kinase 1), a protein that mediates apoptosis, inflammation, and fibrosis. Seal Rock is currently focusing its efforts on hepatic indications including NASH (non-alcoholic steatohepatitis), a condition resulting from fatty liver disease, characterized by hepatic inflammation and cellular damage that lead to liver fibrosis. Additional opportunities with ASK1 inhibitors include cardiac, immunological and neurodegenerative indications.Seal Rock Therapeutics Address
500 Yale Ave NSeattle, WA
United States